10-Q
Quarterly Report
ALTO INGREDIENTS, INC.
ALTO
NASDAQ
CIK: 778164
File #: 000-21467
Balance Sheet
52 line items · 2 periods
XBRL
| Item | Jun 30, 2024 | Dec 31, 2023 |
|---|---|---|
ASSETS | ||
Current Assets: | ||
Cash and cash equivalents | 27,124,000 | 30,014,000 |
Restricted cash | 1,287,000 | 15,466,000 |
Cash collateral balance | 1,287,000 | 15,466,000 |
Accounts receivable, net (net of allowance for credit losses of $26 and $85, respectively) | 64,081,000 | 58,729,000 |
Inventories | 49,434,000 | 52,611,000 |
Derivative instruments | 5,606,000 | 2,412,000 |
Commodity contracts | 5,606,000 | 2,412,000 |
Derivative Financial Instruments, Assets | 5,606,000 | 2,412,000 |
Derivative Financial Instruments, Assets - Fair Value, Inputs, Level 1 | 5,606,000 | 2,412,000 |
Other current assets | 6,126,000 | 9,538,000 |
Total current assets | 153,658,000 | 168,770,000 |
Property and equipment, net | 244,893,000 | 248,748,000 |
Other Assets: | ||
Right of use operating lease assets, net | 20,404,000 | 22,597,000 |
Intangible assets, net | 8,204,000 | 8,498,000 |
Other assets | 5,339,000 | 5,628,000 |
Total other assets | 33,947,000 | 36,723,000 |
Total Assets | 432,498,000 | 454,241,000 |
Pekin Campus | 236,722,000 | 251,048,000 |
Marketing and distribution | 103,982,000 | 101,196,000 |
Western production | 57,677,000 | 57,533,000 |
Corporate and other[ Member] | 34,117,000 | 44,464,000 |
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
Current Liabilities: | ||
Accounts payable | 20,132,000 | 20,752,000 |
Accrued liabilities | 16,504,000 | 20,205,000 |
Current portion – operating leases | 4,481,000 | 4,333,000 |
Derivative instruments | 2,764,000 | 13,849,000 |
Commodity contracts | 2,764,000 | 13,849,000 |
Derivative Financial Instruments, Liabilities | (2,764,000) | 13,849,000 |
Fair Value, Inputs, Level 1 - Derivative Financial Instruments, Liabilities | (2,764,000) | 13,849,000 |
Other current liabilities | 5,886,000 | 6,149,000 |
Total current liabilities | 49,767,000 | 65,288,000 |
Long-term debt, net | 90,960,000 | 82,097,000 |
Operating leases, net of current portion | 16,828,000 | 19,029,000 |
Other liabilities | 9,120,000 | 8,270,000 |
Total Liabilities | 166,675,000 | 174,684,000 |
Stockholders’ Equity: | ||
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of June 30, 2024 and December 31, 2023; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of June 30, 2024 and December 31, 2023; liquidation preference of $18,075 as of June 30, 2024 | 1,000 | 1,000 |
Common stock, value | 77,000 | 76,000 |
Additional paid-in capital | 1,042,639,000 | 1,040,912,000 |
Accumulated other comprehensive income | 2,481,000 | 2,481,000 |
Accumulated deficit | (779,375,000) | (763,913,000) |
Total stockholders’ equity | 265,823,000 | 279,557,000 |
Preferred Stock | 1,000 | 1,000 |
Common Stock | 77,000 | 76,000 |
Additional Paid-In Capital | 1,042,639,000 | 1,040,912,000 |
Accumulated Deficit | (779,375,000) | (763,913,000) |
Accum. Other Comprehensive Income | 2,481,000 | 2,481,000 |
Total Liabilities and Stockholders’ Equity | 432,498,000 | 454,241,000 |